Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin L Ebert

Showing results (171-180 of 339) with videos related to

Pageof 34
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 2, 2022
Clonal Hematopoiesis and Mosaicism Revealed by a Multi-Tissue Analysis of Constitutional TP53 StatusDanielle Castillo, Tze-An Yuan, Bita Nehoray, et al.
Leukemia|September 23, 2022
Activity of menin inhibitor ziftomenib (KO-539) as monotherapy or in combinations against AML cells with MLL1 rearrangement or mutant NPM1Warren Fiskus, Naval Daver, Steffen Boettcher, et al.
Blood|September 17, 2014
TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patientsRafael Bejar, Allegra Lord, Kristen Stevenson, et al.
Nature Medicine|March 19, 2013
Macrophages support pathological erythropoiesis in polycythemia vera and β-thalassemiaPedro Ramos, Carla Casu, Sara Gardenghi, et al.
Nature Communications|March 26, 2014
Mutations in epigenetic regulators including SETD2 are gained during relapse in paediatric acute lymphoblastic leukaemiaBrenton G Mar, Lars B Bullinger, Kathleen M McLean, et al.
Cancer Cell|June 15, 2010
Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cellsAnn Mullally, Steven W Lane, Brian Ball, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2008
Identification of an evolutionarily conserved transcriptional signature of CD8 memory differentiation that is shared by T and B cellsW Nicholas Haining, Benjamin L Ebert, Aravind Subrmanian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2024
Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin LymphomaChengcheng Yan, Melissa A Richard, Christopher J Gibson, et al.
Blood|March 15, 2013
Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-α in a murine model of polycythemia veraAnn Mullally, Claudia Bruedigam, Luke Poveromo, et al.
Blood|March 18, 2020
Clonal hematopoiesis in donors and long-term survivors of related allogeneic hematopoietic stem cell transplantationSteffen Boettcher, C Matthias Wilk, Jochen Singer, et al.
Pageof 34

Showing results (171-180 of 339) with videos related to

Sort By:
Pageof 34
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 2, 2022
Clonal Hematopoiesis and Mosaicism Revealed by a Multi-Tissue Analysis of Constitutional TP53 StatusDanielle Castillo, Tze-An Yuan, Bita Nehoray, et al.
Leukemia|September 23, 2022
Activity of menin inhibitor ziftomenib (KO-539) as monotherapy or in combinations against AML cells with MLL1 rearrangement or mutant NPM1Warren Fiskus, Naval Daver, Steffen Boettcher, et al.
Blood|September 17, 2014
TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patientsRafael Bejar, Allegra Lord, Kristen Stevenson, et al.
Nature Medicine|March 19, 2013
Macrophages support pathological erythropoiesis in polycythemia vera and β-thalassemiaPedro Ramos, Carla Casu, Sara Gardenghi, et al.
Nature Communications|March 26, 2014
Mutations in epigenetic regulators including SETD2 are gained during relapse in paediatric acute lymphoblastic leukaemiaBrenton G Mar, Lars B Bullinger, Kathleen M McLean, et al.
Cancer Cell|June 15, 2010
Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cellsAnn Mullally, Steven W Lane, Brian Ball, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2008
Identification of an evolutionarily conserved transcriptional signature of CD8 memory differentiation that is shared by T and B cellsW Nicholas Haining, Benjamin L Ebert, Aravind Subrmanian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2024
Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin LymphomaChengcheng Yan, Melissa A Richard, Christopher J Gibson, et al.
Blood|March 15, 2013
Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-α in a murine model of polycythemia veraAnn Mullally, Claudia Bruedigam, Luke Poveromo, et al.
Blood|March 18, 2020
Clonal hematopoiesis in donors and long-term survivors of related allogeneic hematopoietic stem cell transplantationSteffen Boettcher, C Matthias Wilk, Jochen Singer, et al.
Pageof 34